Literature DB >> 21993485

Urosepsis--from the view of the urologist.

Florian M E Wagenlehner1, Adrian Pilatz, Wolfgang Weidner.   

Abstract

Urosepsis accounts for approximately 25% of all sepsis cases and may develop from a community-or nosocomial-acquired urinary tract infection (UTI). The underlying UTI is almost exclusively a complicated one with involvement of parenchymatous urogenital organs (e.g. kidneys, prostate). In urosepsis, as in other types of sepsis, the severity of sepsis depends mostly upon the host response. The urological management of urosepsis comprises early diagnosis, early fluid and oxygen treatment, early antibiotic therapy and early control of the complicating factor in the urinary tract. Time from admission to therapy is critical. The shorter the time to effective treatment, the higher is the success rate. This aspect has to become incorporated into the organisational process, including urologists, radiologists and intensive care specialists amongst others. Adequate initial antibiotic therapy has to be insured. This goal implies, however, a wide array of measures over time to ensure a rational antibiotic policy, including microbiologists and clinical pharmacologists. Dosage of an antibiotic in the septic patient generally has to be high to ensure adequate pharmacological exposure in the individual patient.
Copyright © 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993485     DOI: 10.1016/j.ijantimicag.2011.09.007

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  22 in total

1.  A nanofilter for fluidic devices by pillar-assisted self-assembly microparticles.

Authors:  Tamer AbdelFatah; Mahsa Jalali; Sara Mahshid
Journal:  Biomicrofluidics       Date:  2018-11-19       Impact factor: 2.800

2.  Prevalence and pathogenesis of extended-spectrum beta-lactamase producing Escherichia coli causing urinary tract infection in hospitalized patients.

Authors:  A Gündoğdu; Y B Long; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-24       Impact factor: 3.267

Review 3.  Urosepsis--Etiology, Diagnosis, and Treatment.

Authors:  Nici Markus Dreger; Stephan Degener; Parviz Ahmad-Nejad; Gabriele Wöbker; Stephan Roth
Journal:  Dtsch Arztebl Int       Date:  2015-12-04       Impact factor: 5.594

4.  Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial.

Authors:  Ahmed M Elshal; Ahmed M Atwa; Ahmed R El-Nahas; Mohamed A El-Ghar; Asaad Gaber; Essam Elsawy; Abdelwahab Hashem; Yasser Farag; Hashim Farg; Ali Elsorougy; Mohamed Fouda; Hossam Nabeeh; Ahmed Mosbah
Journal:  World J Urol       Date:  2018-05-07       Impact factor: 4.226

5.  Digital Quantification of DNA Replication and Chromosome Segregation Enables Determination of Antimicrobial Susceptibility after only 15 Minutes of Antibiotic Exposure.

Authors:  Nathan G Schoepp; Eugenia M Khorosheva; Travis S Schlappi; Matthew S Curtis; Romney M Humphries; Janet A Hindler; Rustem F Ismagilov
Journal:  Angew Chem Int Ed Engl       Date:  2016-06-30       Impact factor: 15.336

6.  Comparison of the clinical efficacy and safety of retroperitoneal laparoscopic ureterolithotomy and ureteroscopic holmium laser lithotripsy in the treatment of obstructive upper ureteral calculi with concurrent urinary tract infections.

Authors:  Jun-Tao Jiang; Wei-Guo Li; Yi-Ping Zhu; Wen-Lan Sun; Wei Zhao; Yuan Ruan; Chen Zhong; Kristofer Wood; Hai-Bin Wei; Shu-Jie Xia; Xiao-Wen Sun
Journal:  Lasers Med Sci       Date:  2016-04-07       Impact factor: 3.161

7.  Seven hours to adequate antimicrobial therapy in urosepsis using isothermal microcalorimetry.

Authors:  Olivier Braissant; Georg Müller; Adrian Egli; Andreas Widmer; Reno Frei; Armin Halla; Dieter Wirz; Thomas C Gasser; Alexander Bachmann; Florian Wagenlehner; Gernot Bonkat
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

8.  Association of interleukin-10 gene promoter polymorphisms with susceptibility to acute pyelonephritis in children.

Authors:  Juraj Javor; Karol Králinský; Eva Sádová; Oľga Červeňová; Mária Bucová; Michaela Olejárová; Milan Buc; Adriana Liptáková
Journal:  Folia Microbiol (Praha)       Date:  2014-01-22       Impact factor: 2.099

9.  A novel use of attenuation value (Hounsfield unit) in non-contrast CT: diagnosis of pyonephrosis in obstructed systems.

Authors:  Ismail Basmaci; Ertugrul Sefik
Journal:  Int Urol Nephrol       Date:  2019-09-20       Impact factor: 2.370

10.  Clinical factors associated with shock in bacteremic UTI.

Authors:  Katsumi Shigemura; Kazushi Tanaka; Kayo Osawa; Sochi Arakawa; Hideaki Miyake; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2013-04-25       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.